Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01785030 · ClinicalTrials.gov registry record · Phase 1

Nitrous Oxide Vasodilation Healthy Adult Volunteers

A Phase 1 study, sponsored by Columbia University.

Terminated
Registry status
Phase 1
Development phase
7
Enrollment target

NCT01785030: Clinical Trial Phase 1 study, sponsored by Columbia University.

NCT01785030 is a Phase 1 study that was terminated before completion, run by Columbia University. The registered enrollment target is 7 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01785030, a Phase 1 study, was terminated before completion, sponsored by Columbia University.

TERMINATED
Registry status
Phase 1
Development phase
7 participants
Enrollment target

Study Summary

Nitrous oxide (N2O) is a gas that is normally used to take away pain and anxiety during painful medical procedures. However, one of its effects is to also make veins appear larger and more visible. This is useful when there is a patient who needs to have an intravenous (IV) needle put in their skin to give them medicine or fluids, but may have veins that are very hard to see or feel. The mechanism of this observed effect is not entirely clear. The purpose of this study is to use an ultrasound to directly measure whether there is an actual change size of veins or change in blood flow in healthy adult volunteers when you give them 50% nitrous oxide, and see whether or not this change in size, or change in flow, is what causes the changes in visibility or palpability of the vein.

Interventions

  • DRUG 50% Nitrous oxide

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2013-02
Est. Completion 2017-02
Phase Phase 1
Columbia University

958 total trials

Why NCT01785030 stopped before completion

NCT01785030 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 1 intervention - of which 50% Nitrous oxide is the first listed.

NCT01785030 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01785030 about?

NCT01785030 is a clinical study titled "Nitrous Oxide Vasodilation Healthy Adult Volunteers". Nitrous oxide (N2O) is a gas that is normally used to take away pain and anxiety during painful medical procedures. However, one of its effects is to also make veins appear larger and more visible. This is useful when there is a patient who needs to have an intravenous (IV) needle put in their skin ...

What is the current status of trial NCT01785030?

This trial is currently terminated. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2013-02. Estimated completion is 2017-02.

What interventions are being tested in trial NCT01785030?

The interventions under investigation include: 50% Nitrous oxide (DRUG).

Who is sponsoring clinical trial NCT01785030?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01785030's enrollment target sits among peer trials

7 1972nd of 2000 higher than 27 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01785030, the US trial registry maintained by the National Library of Medicine. NCT01785030 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.